JPS643880B2 - - Google Patents

Info

Publication number
JPS643880B2
JPS643880B2 JP55106774A JP10677480A JPS643880B2 JP S643880 B2 JPS643880 B2 JP S643880B2 JP 55106774 A JP55106774 A JP 55106774A JP 10677480 A JP10677480 A JP 10677480A JP S643880 B2 JPS643880 B2 JP S643880B2
Authority
JP
Japan
Prior art keywords
compound
solvent
group
spectrum
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55106774A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5735599A (en
Inventor
Hiroaki Takayama
Sachiko Yamada
Masayuki Oomori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP10677480A priority Critical patent/JPS5735599A/ja
Priority to US06/287,052 priority patent/US4344888A/en
Priority to CA000383164A priority patent/CA1177480A/en
Priority to EP81106150A priority patent/EP0045524B1/en
Priority to AT81106150T priority patent/ATE5077T1/de
Priority to DE8181106150T priority patent/DE3161243D1/de
Publication of JPS5735599A publication Critical patent/JPS5735599A/ja
Publication of JPS643880B2 publication Critical patent/JPS643880B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • C07C29/103—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
JP10677480A 1980-08-05 1980-08-05 24,25-dihydroxycholestane and its preparation Granted JPS5735599A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP10677480A JPS5735599A (en) 1980-08-05 1980-08-05 24,25-dihydroxycholestane and its preparation
US06/287,052 US4344888A (en) 1980-08-05 1981-07-27 24,25-Dihydroxycholestans and process for preparing the same
CA000383164A CA1177480A (en) 1980-08-05 1981-08-04 24,25-dihydroxycholestans and process for preparing the same
EP81106150A EP0045524B1 (en) 1980-08-05 1981-08-05 22-arylsulfonyl-24,25-dihydroxycholestanes and process for preparing the same
AT81106150T ATE5077T1 (de) 1980-08-05 1981-08-05 22-arylsulfonyl-24,25-dihydroxy-cholestane und verfahren zu ihrer herstellung.
DE8181106150T DE3161243D1 (en) 1980-08-05 1981-08-05 22-arylsulfonyl-24,25-dihydroxycholestanes and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10677480A JPS5735599A (en) 1980-08-05 1980-08-05 24,25-dihydroxycholestane and its preparation

Publications (2)

Publication Number Publication Date
JPS5735599A JPS5735599A (en) 1982-02-26
JPS643880B2 true JPS643880B2 (index.php) 1989-01-23

Family

ID=14442243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10677480A Granted JPS5735599A (en) 1980-08-05 1980-08-05 24,25-dihydroxycholestane and its preparation

Country Status (6)

Country Link
US (1) US4344888A (index.php)
EP (1) EP0045524B1 (index.php)
JP (1) JPS5735599A (index.php)
AT (1) ATE5077T1 (index.php)
CA (1) CA1177480A (index.php)
DE (1) DE3161243D1 (index.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4074922A1 (en) 2021-04-16 2022-10-19 Max Co., Ltd. Binding machine

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE15050T1 (de) * 1981-04-29 1985-09-15 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
US4594340A (en) * 1984-11-29 1986-06-10 Hoffmann-La Roche Inc. 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US5218109A (en) * 1988-07-05 1993-06-08 Kuraray Co., Ltd. Steroid compounds
HU212926B (en) * 1990-08-18 1996-12-30 Schering Ag Microbiological method for the preparation of 20-methyl-5,7-pregnadiene-3 beta, 21-diol derivatives
WO2025108575A1 (en) 2023-11-21 2025-05-30 Roche Diagnostics Gmbh Methods of selective deprotection and synthesis of transhydrindane- skeleton-based compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994878A (en) * 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
US4028349A (en) * 1976-03-08 1977-06-07 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof
US4026882A (en) * 1976-03-08 1977-05-31 Hoffmann-La Roche Inc. Syntheses of 3,24R,25- and 3,24S,25-trihydroxy-5,7-cholestadiene 24,25-ketals and alkanoyl derivatives thereof
CH626336A5 (en) * 1976-03-08 1981-11-13 Hoffmann La Roche Process for the preparation of cholecalciferol derivatives
US4204995A (en) * 1978-03-15 1980-05-27 Hoffmann-La Roche Inc. Cholestane derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4074922A1 (en) 2021-04-16 2022-10-19 Max Co., Ltd. Binding machine

Also Published As

Publication number Publication date
DE3161243D1 (en) 1983-11-24
JPS5735599A (en) 1982-02-26
ATE5077T1 (de) 1983-11-15
US4344888A (en) 1982-08-17
CA1177480A (en) 1984-11-06
EP0045524A1 (en) 1982-02-10
EP0045524B1 (en) 1983-10-19

Similar Documents

Publication Publication Date Title
EP0390097B1 (en) 1 alpha,25-dihydroxyvitamin D4 compounds, ergosta-5,7-diene compounds and processes for the preparation thereof
JPS5840960B2 (ja) ヒドロキシコレステロ−ル立体異性体間の相互変換法
JP2505669B2 (ja) コレカルシフェロ―ル誘導体の製造に用いる新規化合物およびその製法
JPS643880B2 (index.php)
JPS6129360B2 (index.php)
JPH05271182A (ja) １α，７，８−トリヒドロキシビタミンＤ化合物
DE69005709T2 (de) Adduktaldehyd und seine Anwendung in der Herstellung von Vitamin-D-Derivaten.
US4026882A (en) Syntheses of 3,24R,25- and 3,24S,25-trihydroxy-5,7-cholestadiene 24,25-ketals and alkanoyl derivatives thereof
JPH05222089A (ja) １α，３β，２５−トリヒドロキシ−２４−ホモコレスタ−５，２２−ジエン化合物
JPS5823660A (ja) １α―ヒドロキシビタミンＤまたは１α―ヒドロキシ―プレビタミンＤ化合物の製造方法
US4298537A (en) Process for producing steroid compounds having an oxo group in the side chain
JPS6157836B2 (index.php)
JP2984406B2 (ja) ステロイド誘導体の製造法
JP3588367B2 (ja) １β−ヒドロキシ−１α−低級アルキルビタミンＤ誘導体
JP2750170B2 (ja) ステロイド誘導体の製造法
JP3483155B2 (ja) １α，２５−ジヒドロキシビタミンＤ４およびＤ７の製造法
JPS6352636B2 (index.php)
JP3105973B2 (ja) 活性型ビタミンｄ誘導体の製造法
JP2782244B2 (ja) 新規なビタミンｄ▲下２▼フッ素誘導体
JP2826168B2 (ja) ステロイド誘導体及びその製造方法
JP2953665B2 (ja) ステロイド誘導体の製造方法
JP3785221B2 (ja) ステロイド誘導体およびその製法
JP2683395B2 (ja) ステロイド誘導体
JPH0825993B2 (ja) ビタミンｄ２およびｄ３又は活性型ビタミンｄ２およびｄ３の製造方法，並びにその中間体
JPS6028986A (ja) ステロイドの製造法